Daptomycin injection recalled due to manufacturing compliance deviations
Accord Healthcare recalls Daptomycin for Injection in the US, Puerto Rico, and Canada affecting 65,233 vials due to Current Good Manufacturing Practice (CGMP) deviations found during FDA inspection.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall based on manufacturing compliance deviations with no reported illnesses, injuries, or hospitalizations. The recall is precautionary in nature and meets the rubric criterion for voluntary precautionary recalls.
Plain-English summary
Accord Healthcare, Inc. is recalling Daptomycin for Injection (350 mg/vial) distributed in the United States, Puerto Rico, and Canada. The recall affects 65,233 vials across multiple batches with expiration dates ranging from September 2023 to August 2025. The affected product is available in single-dose vials and in packages of 10 vials.
The recall follows an FDA inspection that identified Current Good Manufacturing Practice (CGMP) deviations. The source does not specify the particular nature of these deviations or report any confirmed illnesses, injuries, or product-related adverse events.
Patients currently taking this medication should contact their healthcare provider if they have questions about their prescription. Healthcare providers and pharmacists should verify whether their inventory contains affected batch numbers and coordinate with their suppliers and Accord Healthcare for product replacement.
The recalled product
- Product
- DAPTOMYCIN (DAPTOMYCIN)
- Brand
- DAPTOMYCIN
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug — Injectable Antibiotic
- Affected units
- 65,233
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Batches: a) R2101274
- Exp. Date 9/30/2023
- R2200161
- Exp. Date 1/31/2025
- R2200506
- R2200697
- Exp. Date 4/30/2025
- R2201107
- Exp. Date 7/31/2025
- b) R2101471
- R2200588
- R2201333
- R2201361
- Exp. Date 8/31/2025
UPCs (4)
- 0316729434058
- 0316729434454
- 316729434058
- 316729434454
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 67 recalled by Accord Healthcare, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 67 products in this recall →Related recalls
Same brand · DAPTOMYCIN
- ModerateDaptomycin Injectable Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2023-03-08
- SevereMylan Recalls Daptomycin Injection Due to Particulate Matter
FDA (Drugs) · 2020-08-12
Same manufacturer · Accord Healthcare, Inc.
See all →- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
Same hazard · cgmp violation
See all →- Moderatevite20 Antifungal Cream recalled due to stability testing deviations
FDA (Drugs) · 2026-07-08
- ModerateNeuroquell products recalled over current good manufacturing practice violations
FDA (Drugs) · 2025-09-17
- ModerateOptim V Anti-Itch Cream Recalled for Current Good Manufacturing Practice Deviations
FDA (Drugs) · 2025-05-28
- ModerateNature Mint Anticavity Fluoride Toothpaste Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateRapidol Hydrocortisone 1% Anti-Itch Cream Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28